HOME ABOUT US HOW IT WORKS PRODUCT PUBLICATIONS THE TEAM CONTACT US
Welcome
DETECTION OF VOLATILE ORGANIC
COMPOUNDS FOR CANCER
SCREENING AND DIAGNOSIS
The SIVO-1 system

Welcome Welcome
SIVO-1 Capture tab
The SIVO-1 instrument is a gas sensor analysis instrument designed exclusively for the analysis of VOC's captured on our unique sensor tab. It is currently a single tab instrument which can easily be scaled to a higher throughput version.

We have developed a unique microextraction and concentration tab, the C-tab, for the simple and convenient capture of VOC's from a urine or breath sample. The compounds once captured remain stable and the tab can be analysed at the point of collection or simply posted to a central laboratory.
  •  Stand alone benchtop instrument
  •  10 minute analysis time
  •  Easy to use touch screen
  •  Data processed by neural network-based pattern recognition software
  •  Just insert the tab and press start
  • Unique single use tab
  • Collects and concentrates VOC's
  • Stable and can be transported at room temperatures
Benefits to the clinician Cost benefits
  • Simple to use unique tab for the collection and concentration of VOC's from urine samples
  • Five minutes collection protocol suitable for use at the GP office or at home
  • Stable to allow postal delivery to a central laboratory
  • 10 minute analysis in SensAm's SIVO-1 instrument
  • Non-invasiva procedure to screen out negative samples
  • Reduce the numbers of samples to be processed downstream and remove the bottle necks in capacity restrained procedures
  • Significant savings due to fewer referrals and fewer costly procedures
  • Reduction in demand on resources and infrastructure
Clinical Data

Welcome Study 1: Risk stratify of colorectal surveillance patients using FIT tests and SIVO-1
  •  Matching stool (FIT test) and urine (VOC test) samples n=255
See publication 1 for details and results

Study 2: 140 cases* were recruited from University Hospital Coventry and
Warwickshire and tested using the SIVO-1 system

  •  Hepatocellular carcinoma (HCC): n=31
  •  Prostate carcinoma (PCA): n=62
  •  Urinary bladder carcinoma (BCA): n=29
  •  Non cancer: n=18 (controls)
See publication 2 for details and results

Study 3: Bladder cancer (BCa): VOCs arising from urine and breath
  •  Urine (n=40) vs. controls (n=50)
  •  Breath (n=60) vs. controls (n=55)
See publication 3 for details and results

email
Copyright © SENSAM Ltd.